Illumina, Inc. (ILMN) CEO Francis deSouza Presents at J.P. Morgan 39th Annual Healthcare Conference (Transcript)Seeking Alpha • 01/12/21
Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic ProfilingBusiness Wire • 01/11/21
Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance InfrastructureBusiness Wire • 01/06/21
Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease TestingBusiness Wire • 12/08/20
Illumina, Inc. (ILMN) Presents at Piper Sandler Healthcare Broker Conference Call - (Transcript)Seeking Alpha • 12/04/20
PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global MarketsBusiness Wire • 12/01/20
Wild Ride For Illumina Stock Shows Promise, Challenge Of Multi-Cancer Blood TestsInvestors Business Daily • 11/13/20
Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent KitBusiness Wire • 11/12/20
Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNABusiness Wire • 11/12/20